Leafly Holdings, Inc. (NASDAQ:LFLY), a leading online cannabis discovery marketplace and resource for cannabis consumers, today announced a new program that allows accredited cannabis researchers to supplement their work with a large cannabis dataset that would otherwise not be available.
Credit Suisse Downgrades Fulcrum Therapeutics to Neutral, Lowers Price Target to $8
Credit Suisse analyst Judah Frommer downgrades Fulcrum Therapeutics (NASDAQ:FULC) from Outperform to Neutral and lowers the price target from $11 to $8.